A Case of Granulomatous Rosacea: Successful treatment with Topical Azelaic acid 20% cream / Granulomatozna rozacea – lokalno lečenje azelaičnom kiselinom u obliku 20% krema – prikaz slučaja

Open access


Granulomatous rosacea is considered to be the only true variant of rosacea. Diascopy of larger lesions often reveals apple-jelly nodules, indicating their granulomatous histology. Other signs and symptoms of rosacea are not required to make a diagnosis of granulomatous rosacea. The response to treatment may be slow, which must be the most important consideration for both the clinician and the patient. We present an otherwise healthy 62-year-old non-atopic woman with a 15-year history of episodic facial flushing, often accompanied by a burning sensation without sweating. Exclusively affecting the face, lesions had a high tendency to spread each year. The patient was a lifelong non-smoker. A seller on the local market, she spent most of her time outdoors. She had no positive family history of rosacea. At the time of presentation, she was not taking any medications, except for topical neutral creams. Multiple reddish-brown papules without comedones, associated with telangiectasia were scattered over the erythematous background on the chin, forehead, cheeks, nose, glabella and eyelids, while small pustules clustered over the eyelids. The nasolabial folds, neck and ears were not affected. There was neither lymphadenopathy, nor ocular involvement. Based on the history, physical, laboratory and other relevant investigations including histopathology, the diagnosis of granulomatous rosacea was established. The therapy was conducted with topical azelaic acid 20% cream, twice daily for six months. Clinical evaluation was done every 14 days during the first month, and once monthly during the next five months. Affter two weeks, there was a significant decrease in the mean inflammatory lesion count. At the end of the therapy, telangiectasia and facial erythema almost disappeared. There were no side effects. Apart from several short episodes of erythema, during the five-year-long follow-up, there were no other signs of the disease. In conclusion, azelaic acid 20% cream may be an effective and safe treatment option for some patients with granulomatous rosacea.

1. Blount BW, Pelletier AL. Rosacea: a common, yet commonly overlooked, condition. Am Acad Fam Phys 2002;66:435-40.

2. Kyriakis KP, Palamaras I, Terzoudi S, Emmanuelides S, Michailides C, Pagana G. Epidemiologic aspects of rosacea. J Am Acad Dermatol 2005;53:918-9.

3. Berth-Jones J. Rosacea, perioral dermatitis and similar dermatoses, flushing and flushing syndromes. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of dermatology. 8th ed. Oxford: Wiley-Blackwell; 2010. p. 43.1-20.

4. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2002;46:584-7.

5. Pelle MT. Rosacea. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick‘s dermatology in general medicine.7th ed. New York: McGraw-Hill; 2008. p. 703-10.

6. Gupta AK, Gover MD. Azelaic acid (15% gel) in the treatment of acne rosacea. Int J Dermatol 2007;46:533-8.

7. Jappe U, Schafer T, Schnuch A, Uter W. Contact allergy in patients with rosacea: a clinical-based prospective epidemiological study. J Eur Acad Dermatol Venereol 2008;22:1208-14.

8. Van de Scheur MR, Van der Waal RI, Starink TM. Lupus miliaris disseminatus faciei: a distinctive rosacea-like syndrome and not a granulomatous form of rosacea. Dermatology 2003;206:120-3.

9. Ioffreda MD. Inflammatory disorders of hair follicles, sweat glands, and cartilage. In: Elder DE, editor. Lever‘s histopathology of the skin. 9th ed. Philadelphia: Lippincott Williams & Wilkins. 2005. p. 469-512.

10. Abram K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol 2010;24:565-71.

11. Yuuren EJ, Gupta AK, Gover MD, Graber M, Hollis S. Systematic review of rosacea treatments. J Am Acad Dermatol Venereol 2007;56:107-15.

12. Karabulut AA, Izol Setrel B, Eksioglu HM. A randomized, single-blind, placebo controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea. J Eur Acad Dermatol Venereol 2008;2002:729-34.

13. Mostafa FF, El Harras MA, Gooma SM, Al Mokadem S, Nassar AA, Abdel Gawad EH. Comparative study of some treatment modalities of rosacea. J Eur Acad Dermatol Venereol 2009;23:22-8.

14. Sehgal VN, Sharma S, Sardana K. Rosacea-acne rosacea: efficacy of combination therapy of azithromycin and topical 0.1% tacrolimus ointment. J Eur Acad Dermatol Venereol 2008;22:1366-8.

Serbian Journal of Dermatology and Venereology

The Journal of Serbian Association of Dermatovenereologists (SAD)

Journal Information


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 156 156 33
PDF Downloads 39 39 15